Home » Authors » Karen Young

Karen Young

Articles

ARTICLES

Vasogen Raises $10.8M For Immune Modulation Therapy

May 8, 2002

Vasogen Raises $10.8M For Immune Modulation Therapy

May 8, 2002

NeoTherapeutics Looking To License Out Drug Candidates

May 8, 2002

Sunesis Collaborates With J&J On Small-Molecule Inhibitors

May 7, 2002

Sunesis Collaborates With J&J On Small-Molecule Inhibitors

May 7, 2002

Trimeris Looks For New Fusion Inhibitors Through Neokimia Deal

May 6, 2002

Thios Completes $15M Round To Work On Role Of Sulfation

May 6, 2002

Trimeris Looks For New Fusion Inhibitors Through Neokimia Deal

May 6, 2002

Thios Completes $15M Round To Work On Role Of Sulfation

May 6, 2002

Nyxis Getting Ready To Move Glyxins Family Into The Clinic

May 3, 2002

View All Articles by Karen Young

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...